Posted on December 8, 2022
Gilead Sciences, Inc. (NASDAQ:GILD) makes up nonsense to profit from people’s fears about the Covid BATFLU virus, HIV and, more recently, cancer.
What’s most astounding, however, is that folks actually believe them.
That’s why the stock has right flown over the last two months, tacking on 46%, while the rest of us choke on graphene oxide dumped from uncharted airplanes buzzing above our cities.
With deference to our Habbani Yemenite brothers, we’re doing exactly that.
Good Jews and Noahides—the Gileadites are about to be delivered into our hands!
Gird your loins and unsheathe your swords!
Be strong and of good courage!
Because there’s absolutely nothing to commend here.
Not even the fundamentals.
But before we get to them, we have one to close for a massive take.
Our FSLR initiative, whose details can be found HERE, has us in possession of a $0.61 credit and holding the January 20th 160 synthetic short.
With FSLR now trading at $154.74, the short can be closed.
Buy back the CALL for $8.45 and sell the PUT for $12.60 and you walk with $4.76 on an initial outlay of ZILCH.
Adjusted for minimal commissions gives you a profit of 3073%!
And that’s the glory of G-d.
Back to the subject at hand…
Here are some numbers—
So what’s the hubbub…?
It seems someone on the sell-side started talking this one up a little too friskily, got everyone tickled and the masses simply followed along.
There are certain comely analysts, don’t you know, who develop a following because they’re less than modestly attired—G-d help us.
But that will never justify what we find on the following chart (regardless how many invasive fungal infections the company claims to have saved us from).
Prayer helps in everything, fellow Jews and Noahides! Our Sages of Blessed Memory inform us that what’s prayed for and received is permanent. What’s received without prayer… is possessed only temporarily.
So belt it out!
Many happy returns!